Metysolon contains the active substance methylprednisolone, which is a glucocorticoid (hormone of the adrenal gland) that acts on metabolism, saline balance (electrolytes) and tissue function.
Metysolon is indicated for the treatment of diseases that require systemic therapy with glucocorticoids. These include, depending on the appearance and severity, e.g.:
Rheumatic diseases
Bronchial and lung diseases
Diseases of upper airways
Skin diseases
Blood diseases / Tumor diseases
Gastrointestinal diseases
Hormonal replacement therapy
Metysolon 4 mg can be used also:
to suppress the body’s defense (immunosuppression) after transplantation in the context of conventional combination therapies,
as a complementary measure in cytostatic or radiotherapy in existing schemes for combination therapy, palliative therapy (disease-reducing treatment) and antiemetic therapy (treatment against vomiting).